Molecular model of cyclin-dependent kinase 5 complexed with roscovitine

Biochemical and Biophysical Research Communications

Volumn 297, Issue 5, 2002, Pages 1154-1158

  De Azevedo Jr , Walter Filgueira ^a,b   Tadeu Gaspar, Renato ^a   Canduri, Fernanda ^a,b   Carlos Camera Jr , João ^a   José Freitas da Silveira, Nelson ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

Bioinformatics; CDK; Drug design; Roscovitine; Structure

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 5; ROSCOVITINE;

ARTICLE; BINDING AFFINITY; DRUG EFFECT; ENZYME BINDING; ENZYME INHIBITION; ENZYME STRUCTURE; HYDROGEN BOND; MOLECULAR MODEL; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

ADENINE; ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; CDC2-CDC28 KINASES; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; PURINES; SEQUENCE HOMOLOGY, AMINO ACID; SOFTWARE;

EID: 0036399607     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02352-5     Document Type: Article

References (26)

1. C. Norbury, P. Nurse, Animal cell cycles and their control, Annu. Rev. Biochem. 61 (1992) 441-470.
2. W.F. de Azevedo Jr., H.J. Mueller-Dieckmann, U. Schulze-Gahmen, P.J. Worland, E. Sausville, S.-H. Kim, Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase, Proc. Natl. Acad. Sci. USA 93 (7) (1996) 2735-2740.
3. W.F. de Azevedo Jr., S. Leclerc, L. Meijer, L. Havlicek, M. Strnad, S.-H. Kim, Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human CDK2 complexed with roscovitine, Eur. J. Biochem. 243 (1997) 518-526.
4. G.N. Patrick, L. Zuckerberg, M. Nikolic, S. de la Monte, P. Dikkes, L.H. Tsai, Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration, Nature 402 (6762) (1999) 615-622.
5. R.B. Maccioni, C. Otth, I.I. Concha, J.P. Muñoz, The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology, Eur. J. Biochem. 268 (6) (2001) 1518-1527.
6. S.H. Chao, K. Fujinaga, J.E. Marion, R. Taube, E.A. Sausville, A.M. Senderowicz, B.M. Peterlin, D.H.J. Price, Flavopiridol inhibits P-TEFb and blocks HIV-1 replication, J. Biol. Chem. 275 (37) (2000) 28345-28348.
7. N. Gray, L. Detivaud, C. Doerig, L.C. Meijer, ATP-site directed inhibitors of cyclin-dependent kinases, Curr. Med. Chem. 6 (9) (1999) 859-875.
8. P.M. Clare, R.A. Poorman, L.C. Kelley, K.D. Watenpaugh, C.A. Bannow, K.L. Leach, The cyclin-dependent kinases CDK2 and CDK5 act by a random, anticooperative kinetic mechanism, J. Biol. Chem. 276 (51) (2001) 48292-48299.
9. A. Alvarez, R. Toro, A. Carceres, 3 R.B. Maccioni, Inhibition of tau phosphorylating protein kinase CDK5 prevents β-amyloid-induced neuronal death, FEBS Lett. 459 (3) (1999) 421-426.
10. L. Meijer, A. Borgne, O. Mulner, J.P. Chong, J.J. Blow, N. Inagaki, Biochemical and cellular e4ects of roscovitine, a patent and selective inhibitor of the cyclin-dependent kinases CDK2 and CDK5, Eur. J. Biochem. 243 (1997) 527-536.
11. C. Tarricone, R. Dhavan, J. Peng, L.B. Areces, L.H. Tsai, A. Musacchio, Structure and regulation of the CDK5-p25(nck5a) complex, Mol. Cell 8 (3) (2001) 657-669.
12. P. Sharma, P.J. Steinbach, M. Sharma, N.D. Amin, J.J. Barchi Jr., H.C. Pant, Identification of substrate binding site of cyclin-dependent kinase 5, J. Biol. Chem. 274 (1999) 9600-9606.
13. W.F. de Azevedo Jr., F. Canduri, N.J.F. da Silveira, Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol, Biochem. Biophys. Res. Commun. 293 (2002) 566-571.
14. A. Sali, T.L. Blundell, Comparative protein modelling by satisfaction of spatial restraints, J. Mol. Biol. 234 (1993) 779-815.
15. B.R. Brooks, R.E. Bruccoleri, B.D. Olafson, D.J. States, S. Swaminathan, M. Karplus, CHARMM: a program for macro-molecular energy minimization and dynamics calculations, J. Comp. Chem. 4 (1983) 187-217.
16. W. Braun, N. Go, Calculation of protein conformations by proton-proton distance constraints. A new eQcient algorithm, J. Mol. Biol. 186 (3) (1985) 611-626.
17. R.A. Laskowski, M.W. MacArthur, D.K. Smith, D.T. Jones, E.G. Hutchinson, A.L. Morris, D. Naylor, D.S. Moss, J.M. Thorton, PROCHECK v.3.0-program to check the stereochemistry quality of protein structures-operating instructions, 1994.
18. Collaborative Computational Project No. 4. The CCP4 Suite: programs for protein crystallography, Acta Crystallogr. D 50 (1994) 760-763.
19. H.L. DeBondt, J. Rosenblatt, J. Jancarik, H.D. Jones, D.O. Morgan, S.-H. Kim, Crystal structural of cyclin-dependent kinase 2, Nature (Lond.) 363 (1993) 595-602.
20. S. Serota, E. Radsio-Andzelm, Three protein kinase structures define a common motif, Structure 2 (1994) 345-355.
21. F. Canduri, L.G.V.L. Teodoro, C.C.B. Lorenzi, V. Hial, R.A.S. Gomes, J. Ruggiero Neto, W.F. de Azevedo Jr., Crystal structure of human uropepsin at 2.45 Å resolution, Acta Crystallogr. D 57 (2001) 1560-1570.
22. W.F. de Azevedo Jr., F. Canduri, V. Fadel, L.G.V.L. Teodoro, V. Hial, R.A.S. Gomes, Molecular model for the binary complex of uropepsin and pepstatin, Biochem. Biophys. Res. Commun. 287 (1) (2001) 277-281.
23. S.-H. Kim, U. Schulze-Gahmen, J. Brandsen, W.F. de Azevedo Jr., Structural basis for chemical inhibitor of CDK2, Prog. Cell Cycle Res. 2 (1996) 137-145.
24. A. Nicholls, K.A. Sharp, B. Honig, Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons, Proteins 11 (4) (1991) 281-296.
25. D.G. Higgins, A.J. Bleasby, R. Fuchs, CLUSTAL V: Improved software for multiple sequence alignment, Comput. Appl. Biosci. 8 (2) (1992) 189-191.
26. P. Kraulis, MOLSCRIPT: A program to produce both detailed and schematic plots of proteins, J. Appl. Cryst. 24 (1991) 946-950